Orange Book product · Brand (NDA)
FIBRICOR
FENOFIBRIC ACID
At a glance
Aug 14, 2009
Approved
Brand (NDA)
Application
Not listed
TE code
7
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 14, 2009
17 yr 1 mo ago
Today
Patent 7569612 expires
Listed method-of-use patent (U-1000) expiration.
Aug 20, 2027
in 1 yr 2 mo
Patent 7741373 expires
Listed method-of-use patent (U-1059) expiration.
Aug 20, 2027
in 1 yr 2 mo
Patent 7741374 expires
Listed method-of-use patent (U-1061) expiration.
Aug 20, 2027
in 1 yr 2 mo
Patent 7741374 expires
Listed method-of-use patent (U-1060) expiration.
Aug 20, 2027
in 1 yr 2 mo
Patent 7915247 expires
Listed method-of-use patent (U-1061) expiration.
Aug 20, 2027
in 1 yr 2 mo
Patent 7915247 expires
Listed method-of-use patent (U-1059) expiration.
Aug 20, 2027
in 1 yr 2 mo
Patent 7915247 expires
Listed method-of-use patent (U-1000) expiration.
Aug 20, 2027
in 1 yr 2 mo
Pharmaceutical detail
Active ingredient
FENOFIBRIC ACID
Strength
35MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 022418
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (7)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7569612 | Aug 20, 2027 | in 1 yr 2 mo | U-1000 |
| 7741373 | Aug 20, 2027 | in 1 yr 2 mo | U-1059 |
| 7741374 | Aug 20, 2027 | in 1 yr 2 mo | U-1061 |
| 7741374 | Aug 20, 2027 | in 1 yr 2 mo | U-1060 |
| 7915247 | Aug 20, 2027 | in 1 yr 2 mo | U-1061 |
| 7915247 | Aug 20, 2027 | in 1 yr 2 mo | U-1059 |
| 7915247 | Aug 20, 2027 | in 1 yr 2 mo | U-1000 |
